Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10590085 Heterocyclic amides as kinase inhibitors

Patent 10590085 was granted and assigned to GlaxoSmithKline on March, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

GlaxoSmithKline

Current Assignee

GlaxoSmithKline

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10590085

Patent Inventor Names

Philip Anthony Harris0

Nicolas Eric Faucher0

Nicolas S. George0

Patrick M. Eidam0

Alain Claude-Marie Daugan0

Bryan W. King0

Clark A. Sehon0

David Duff Wisnoski0

...

Date of Patent

March 17, 2020

Patent Application Number

15575235

Date Filed

May 19, 2016

Patent Citations Received

‌

US Patent 10899716 Heterocyclic amides as kinase inhibitors

‌

US Patent 11485710 Heterocyclic amides as kinase inhibitors

Patent Primary Examiner

‌

Samantha L Shterengarts

Patent abstract

Disclosed are compounds having the formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10590085 Heterocyclic amides as kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API